Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers.
Saved in:
| Title: | Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers. |
|---|---|
| Authors: | Collins J; Department of Chemical and Biological Engineering, Colorado School of Mines, Golden, CO, USA., Farnsworth NL; Department of Chemical and Biological Engineering, Colorado School of Mines, Golden, CO, USA. nfarnsworth@mines.edu. |
| Source: | Diabetologia [Diabetologia] 2025 Apr; Vol. 68 (4), pp. 692-703. Date of Electronic Publication: 2025 Jan 23. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0428 |
|---|---|
| DOI: | 10.1007/s00125-024-06356-5 |
